Acción ENBI ENTHEON BIOMEDICAL CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Entheon Biomedical Corp.

Acciones

ENBI

CA29383X2023

Mercado cerrado - Canadian Securities Exchange
Otros sitios de cotización
 15:30:00 05/07/2024 		Varia. Cinco días. Varia. 1 de enero.
0,075 CAD -51,61 % Gráfico intradía de Entheon Biomedical Corp. -51,61 % -25,00 %
04/07 Entheon Biomedical Corp. informa de los resultados del segundo trimestre y de los seis meses finalizados el 31 de mayo de 2024 CI
29/04 Entheon Biomedical Corp. presenta los resultados del primer trimestre finalizado el 29 de febrero de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director
Entheon Biomedical Corp. Announces CFO Changes
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101
Entheon Biomedical : CFO Certification
Entheon Biomedical : CEO Certification
Entheon Biomedical : Quarterly Report
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ENBI
  4. Noticias Entheon Biomedical Corp.
  5. Otros idiomas